• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
IVX 20.0% 0.6¢

INVION LIMITED

Invion Limited is an Australia-based life sciences company. The Company is engaged in the... Invion Limited is an Australia-based life sciences company. The Company is engaged in the research and development of Photosoft technology for the treatment of a range of cancers, atherosclerosis and infectious diseases. The Company is engaged in the clinical development of a PhotoDynamic Therapy (PDT) for cancer. Its photosensitizer (the agent used in PDT) is called IVX-PDT and is based on Photosoft Technology. Its PDT is an alternative to surgery, and in contrast to radiotherapy and chemotherapy, which are immunosuppressive, PDT causes acute inflammation, expression of heat-shock proteins, and invasion and infiltration of a tumor by leukocytes. It produces topical and intravenous products suitable for use in skin cancer and in solid tumors, such as those present in ovarian, prostate and lung cancer. It is developing a topical formulation of its photosensitizing agent, IVX-PDT, to treat superficial Basal Cell Carcinoma (sBCC), Actinic Keratosis (AK) and Squamous Cell Cancer (SCC).More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
IVX
Approval and Commencement of clinical Trials Australian Government Cancer.
09:34 0 93
09:34 Last post  matakus Comments Created with Sketch.  0  Views Created with Sketch.  93 
IVX 08:16 18 5.3K
08:16 Last post  simonaw Comments Created with Sketch.  18  Views Created with Sketch.  5.3K 
IVX 05/03/24 0 256
05/03/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  256 
IVX
ACHIEVING ~80% TUMOUR CONTROL IN PRECLINICAL STUDIES
05/03/24 0 180
05/03/24 Last post  cashngrab Comments Created with Sketch.  0  Views Created with Sketch.  180 
IVX 28/02/24 0 243
28/02/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  243 
IVX 24/02/24 2 1.0K
24/02/24 Last post  Rtj1953 Comments Created with Sketch.  2  Views Created with Sketch.  1.0K 
IVX
ASX:IVX - Latest research update on Invion from Pitt Street
24/02/24 2 994
24/02/24 Last post  Chuckm61 Comments Created with Sketch.  2  Views Created with Sketch.  994 
IVX
Invion's Chair and CEO appointed to Advisory Board of Stanford Medicine CARE
16/02/24 0 344
16/02/24 Last post  Rtj1953 Comments Created with Sketch.  0  Views Created with Sketch.  344 

See All Discussions arrow Created with Sketch.

Timeline

Presentation at East-West Summit in Singapore
05 Mar 08:37
 
INV043 With ICI Therapy Achieved 80% Tumour Control For ASCC
04 Mar 16:06
 
Appendix 4D and Half Year Financial Report
28 Feb 09:29
 
Agreement with Dr.inB to develop Photosoft treatment for HPV
23 Feb 09:04
 
Activities Report and Appendix 4C
30 Jan 08:55
 
Change of Director's Interest Notice- Robert Merriel
19 Jan 09:22
 
View More arrow Created with Sketch.
(20min delay)
Last
0.6¢
Change
0.001(20.0%)
Mkt cap ! $38.54M
Open High Low Value Volume
0.5¢ 0.6¢ 0.5¢ $31.31K 5.474M

Buyers (Bids)

No. Vol. Price($)
15 4559223 0.5¢
 

Sellers (Offers)

Price($) Vol. No.
0.6¢ 1446965 2
View Market Depth
Last trade - 16.10pm 29/03/2024 (20 minute delay) ?
Last
0.6¢
  Change
0.001 ( 20.0 %)
Open High Low Volume
0.5¢ 0.6¢ 0.5¢ 1611508
Last updated 14.15pm 29/03/2024 ?
IVX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.